{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:13:22Z","timestamp":1788783202647,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CHU de Limoges"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57614-y","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:57:52Z","timestamp":1781787472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human serum albumin profiling by top-down analysis enables multi-class liver fibrosis staging: a cross-platform validation study"],"prefix":"10.1038","volume":"16","author":[{"given":"Souleiman","family":"El Balkhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Racym","family":"Berrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois Ludovic","family":"Sauvage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Le Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Ali","family":"Rahali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Lakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Saint-Marcoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Loustaud-Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"57614_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12072-015-9665-6","volume":"10","author":"R Spinella","year":"2016","unstructured":"Spinella, R., Sawhney, R. & Jalan, R. Albumin in chronic liver disease: Structure, functions and therapeutic implications. Hepatol. Int. 10, 124\u2013132 (2016).","journal-title":"Hepatol. Int."},{"key":"57614_CR2","doi-asserted-by":"publisher","first-page":"35987","DOI":"10.1038\/srep35987","volume":"6","author":"M Baldassarre","year":"2016","unstructured":"Baldassarre, M. et al. Albumin homodimers in patients with cirrhosis: Clinical and prognostic relevance of a novel identified structural alteration of the molecule. Sci. Rep. 6, 35987 (2016).","journal-title":"Sci. Rep."},{"key":"57614_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/hep.28897","volume":"65","author":"S Das","year":"2017","unstructured":"Das, S. et al. Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis. Hepatology 65, 631\u2013646 (2017).","journal-title":"Hepatology"},{"key":"57614_CR4","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","volume":"59","author":"K Oettl","year":"2013","unstructured":"Oettl, K. et al. Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival. J. Hepatol. 59, 978\u2013983 (2013).","journal-title":"J. Hepatol."},{"key":"57614_CR5","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1002\/hep.30135","volume":"68","author":"J Alcaraz-Quiles","year":"2018","unstructured":"Alcaraz-Quiles, J. et al. Oxidized albumin triggers a cytokine storm in leukocytes through P38 mitogen-activated protein kinase: Role in systemic inflammation in decompensated cirrhosis. Hepatology 68, 1937\u20131952 (2018).","journal-title":"Hepatology"},{"key":"57614_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/1744-9987.12024","volume":"18","author":"RE Stauber","year":"2014","unstructured":"Stauber, R. E. et al. Human nonmercaptalbumin-2: A novel prognostic marker in chronic liver failure. Ther. Apher Dial. 18, 74\u201378 (2014).","journal-title":"Ther. Apher Dial"},{"key":"57614_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep.22913","volume":"50","author":"R Jalan","year":"2009","unstructured":"Jalan, R. et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology 50, 555\u2013564 (2009).","journal-title":"Hepatology"},{"key":"57614_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S2468-1253(24)00234-6","volume":"9","author":"M Jachs","year":"2024","unstructured":"Jachs, M. et al., Group SS-HAS. Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: A modelling study. Lancet Gastroenterol. Hepatol. 9, 1111\u20131120 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"57614_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"A Berzigotti","year":"2021","unstructured":"Berzigotti, A. et al. Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update. J. Hepatol. 75, 659\u2013689 (2021).","journal-title":"J. Hepatol."},{"key":"57614_CR10","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jhep.2024.11.049","volume":"82","author":"P Cales","year":"2025","unstructured":"Cales, P. et al. A new generation of non-invasive tests of liver fibrosis with improved accuracy in MASLD. J. Hepatol. 82, 794\u2013804 (2025).","journal-title":"J. Hepatol."},{"key":"57614_CR11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.27322","volume":"60","author":"M Domenicali","year":"2014","unstructured":"Domenicali, M. et al. Posttranscriptional changes of serum albumin: Clinical and prognostic significance in hospitalized patients with cirrhosis. Hepatology 60, 1851\u20131860 (2014).","journal-title":"Hepatology"},{"key":"57614_CR12","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1002\/hep.31798","volume":"74","author":"M Baldassarre","year":"2021","unstructured":"Baldassarre, M. et al. Determination of effective albumin in patients with decompensated cirrhosis: Clinical and prognostic implications. Hepatology 74, 2058\u20132073 (2021).","journal-title":"Hepatology"},{"key":"57614_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2478\/jtim-2022-0070","volume":"11","author":"M Bernardi","year":"2023","unstructured":"Bernardi, M. Effective albumin - A novel paradigm in the management of decompensated liver cirrhosis. J. Transl Int. Med. 11, 11\u201314 (2023).","journal-title":"J. Transl Int. Med."},{"key":"57614_CR14","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.26338","volume":"58","author":"R Garcia-Martinez","year":"2013","unstructured":"Garcia-Martinez, R. et al. Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology 58, 1836\u20131846 (2013).","journal-title":"Hepatology"},{"key":"57614_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jpba.2017.04.023","volume":"144","author":"M Naldi","year":"2017","unstructured":"Naldi, M., Baldassarre, M., Domenicali, M., Bartolini, M. & Caraceni, P. Structural and functional integrity of human serum albumin: Analytical approaches and clinical relevance in patients with liver cirrhosis. J. Pharm. Biomed. Anal. 144, 138\u2013153 (2017).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"57614_CR16","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41598-024-51412-0","volume":"14","author":"S El Balkhi","year":"2024","unstructured":"El Balkhi, S. et al. Early detection of liver injuries by the Serum enhanced binding test sensitive to albumin post-transcriptional modifications. Sci. Rep. 14, 1434 (2024).","journal-title":"Sci. Rep."},{"key":"57614_CR17","doi-asserted-by":"publisher","first-page":"126239","DOI":"10.1016\/j.ijbiomac.2023.126239","volume":"250","author":"R Lakis","year":"2023","unstructured":"Lakis, R. et al. Semi-synthetic human albumin isoforms: Production, structure, binding capacities and influence on a routine laboratory test. Int. J. Biol. Macromol. 250, 126239 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"57614_CR18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jhep.2014.10.031","volume":"62","author":"R Garcia-Martinez","year":"2015","unstructured":"Garcia-Martinez, R. et al. Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure. J. Hepatol. 62, 799\u2013806 (2015).","journal-title":"J. Hepatol."},{"key":"57614_CR19","doi-asserted-by":"crossref","unstructured":"Gr\u00fcngreiff, K., Gottstein, T., Reinhold, D. & Blindauer, C. A. Albumin substitution in decompensated liver cirrhosis: Don\u2019t forget zinc. Nutrients 13, 4011 (2021).","DOI":"10.3390\/nu13114011"},{"key":"57614_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","volume":"33","author":"G Fanali","year":"2012","unstructured":"Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M. & Ascenzi, P. Human serum albumin: From bench to bedside. Mol. Aspects Med. 33, 209\u2013290 (2012).","journal-title":"Mol. Aspects Med."},{"key":"57614_CR21","doi-asserted-by":"publisher","first-page":"123740","DOI":"10.1016\/j.jchromb.2023.123740","volume":"1224","author":"MA Rahali","year":"2023","unstructured":"Rahali, M. A. et al. Posttranslational-modifications of human-serum-albumin analysis by a top-down approach validated by a comprehensive bottom-up analysis. J. Chromatogr. B Analyt Technol. Biomed. Life Sci. 1224, 123740 (2023).","journal-title":"J. Chromatogr. B Analyt Technol. Biomed. Life Sci."},{"key":"57614_CR22","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1021\/acs.analchem.3c03933","volume":"96","author":"R Lakis","year":"2024","unstructured":"Lakis, R. et al. Absolute quantification of human serum albumin isoforms by internal calibration based on a top-down LC-MS Anal. Chem. ;96:746\u2013755. (2024).","journal-title":"Anal. Chem."},{"key":"57614_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpba.2016.01.048","volume":"122","author":"M Naldi","year":"2016","unstructured":"Naldi, M. et al. Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. J. Pharm. Biomed. Anal. 122, 141\u2013147 (2016).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"57614_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jpba.2014.12.001","volume":"112","author":"M Naldi","year":"2015","unstructured":"Naldi, M. et al. Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. J. Pharm. Biomed. Anal. 112, 169\u2013175 (2015).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"57614_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s42003-021-02269-w","volume":"4","author":"M Paar","year":"2021","unstructured":"Paar, M., Fengler, V. H., Rosenberg, D. J., Krebs, A., Stauber, R. E., Oettl, K. & Hammel, M. Albumin in patients with liver disease shows an altered conformation. Commun. Biol. 4, 731 (2021).","journal-title":"Commun. Biol."},{"key":"57614_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/toxsci\/kft009","volume":"132","author":"S Schomaker","year":"2013","unstructured":"Schomaker, S. et al. Assessment of emerging biomarkers of liver injury in human subjects. Toxicol. Sci. 132, 276\u2013283 (2013).","journal-title":"Toxicol. Sci."},{"key":"57614_CR27","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00432-016-2253-x","volume":"142","author":"B Zhang","year":"2016","unstructured":"Zhang, B. et al. Cytokeratin 18 knockdown decreases cell migration and increases chemosensitivity in non-small cell lung cancer. J. Cancer Res. Clin. Oncol. 142, 2479\u20132487 (2016).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"57614_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/cimb45010006","volume":"45","author":"E Cione","year":"2022","unstructured":"Cione, E. et al. Liver damage and microRNAs: An update. Curr. Issues. Mol. Biol. 45, 78\u201391 (2022).","journal-title":"Curr. Issues. Mol. Biol."},{"key":"57614_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/2211536607666180531093302","volume":"7","author":"K Jampoka","year":"2018","unstructured":"Jampoka, K. et al. Serum miR-29a and miR-122 as potential biomarkers for non-alcoholic fatty liver disease (NAFLD). MicroRNA 7, 215\u2013222 (2018).","journal-title":"MicroRNA"},{"key":"57614_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/0192623312464436","volume":"41","author":"S Starckx","year":"2012","unstructured":"Starckx, S. et al. Evaluation of miR-122 and other biomarkers in distinct acute liver injury in rats. Toxicol. Pathol. 41, 795\u2013804 (2012).","journal-title":"Toxicol. Pathol."},{"key":"57614_CR31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","volume":"70","author":"X Wang","year":"2021","unstructured":"Wang, X., He, Y., Mackowiak, B. & Gao, B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut 70, 784\u2013795 (2021).","journal-title":"Gut"},{"key":"57614_CR32","first-page":"377","volume":"38","author":"C Dietrich","year":"2017","unstructured":"Dietrich, C. et al. Guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (Short Version) Ultraschall in der Medizin -. Eur. J. Ultrasound. 38, 377\u2013394 (2017).","journal-title":"Eur. J. Ultrasound"},{"key":"57614_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jhep.2019.04.020","volume":"71","author":"J Boursier","year":"2019","unstructured":"Boursier, J. et al. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. J. Hepatol. 71, 389\u2013396 (2019).","journal-title":"J. Hepatol."},{"key":"57614_CR34","doi-asserted-by":"crossref","unstructured":"Sebastiani, G. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World J. Gastroenterol. 15, 2190  (2009).","DOI":"10.3748\/wjg.15.2190"},{"key":"57614_CR35","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jhep.2021.12.031","volume":"76","author":"J Boursier","year":"2022","unstructured":"Boursier, J. et al. Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events. J. Hepatol. 76, 1013\u20131020 (2022).","journal-title":"J. Hepatol."},{"key":"57614_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"European Association for Study of L and Asociacion Latinoamericana para el Estudio del H EASL-ALEH Clinical Practice Guidelines","year":"2015","unstructured":"European Association for Study of L and Asociacion Latinoamericana para el Estudio del H EASL-ALEH Clinical Practice Guidelines. Non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol. 63, 237\u2013264 (2015).","journal-title":"J. Hepatol."},{"key":"57614_CR37","doi-asserted-by":"crossref","unstructured":"Boursier, J. et al. ARDENT Group, AFEF. An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standards J Hepatol. ;62:807\u2013815. (2015).","DOI":"10.1016\/j.jhep.2014.10.042"},{"key":"57614_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jhep.2013.09.029","volume":"60","author":"GL Wong","year":"2014","unstructured":"Wong, G. L. et al. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. J. Hepatol. 60, 339\u2013345 (2014).","journal-title":"J. Hepatol."},{"key":"57614_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa, P. & Poynard, T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24, 289\u2013293 (1996).","journal-title":"Hepatology"},{"key":"57614_CR40","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2023.5997","volume":"329","author":"EB Tapper","year":"2023","unstructured":"Tapper, E. B. & Parikh, N. D. Diagnosis and management of cirrhosis and its complications: A review. JAMA 329, 1589\u20131602 (2023).","journal-title":"JAMA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57614-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57614-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57614-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:04:04Z","timestamp":1788782644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57614-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57614"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57614-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9371068\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27911"}}